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Key points
 Fetal heart rate variability (FHRV) has long been recognised as a powerful predictor of
fetal wellbeing, and a decrease in FHRV is associated with fetal compromise. However, the
mechanisms by which FHRV is reduced in the chronically hypoxic fetus have yet to be
established.
 The sympathetic and parasympathetic influences on heart rate mature at different rates
throughout fetal life, and can be assessed by time domain and power spectral analysis of
FHRV.
 In this study of chronically instrumented fetal sheep in late gestation, we analysed FHRV daily
over a 16 day period towards term, and compared changes between fetuses of control and
chronically hypoxic pregnancy.
 WeshowthatFHRVin sheep is reducedbychronichypoxia, predominantlydue todysregulation
of the sympathetic control of the fetal heart rate. This presents a potential mechanism by which
a reduction in indices of FHRV predicts fetuses at increased risk of neonatal morbidity and
mortality in humans.
 Reduction in overall FHRVmay therefore provide a biomarker that autonomic dysregulation of
fetal heart rate control has taken place in a fetus where uteroplacental dysfunction is suspected.
Abstract Although fetal heart rate variability (FHRV) has long been recognised as a powerful
predictor of fetal wellbeing, the mechanisms by which it is reduced in the chronically hypo-
xic fetus have yet to be established. In particular, the physiological mechanism underlying the
reduction of short term variation (STV) in fetal compromise remains unclear. In this study, we
present a longitudinal study of the development of autonomic control of FHRV, assessed by
indirect indices, time domain and power spectral analysis, in normoxic and chronically hypoxic,
chronically catheterised, singleton fetal sheep over the last third of gestation. We used isobaric
chambers able to maintain pregnant sheep for prolonged periods in hypoxic conditions (stable
fetal femoral arterial PO2 10–12 mmHg), and a customised wireless data acquisition system to
record beat-to-beat variation in the fetal heart rate. We determined in vivo longitudinal changes
in overall FHRV and the sympathetic and parasympathetic contribution to FHRV in hypoxic
(n = 6) and normoxic (n = 6) ovine fetuses with advancing gestational age. Normoxic fetuses
show gestational age-related increases in overall indices of FHRV, and in the sympathetic nervous
system contribution to FHRV (P< 0.001). Conversely, gestational age-related increases in overall
FHRV were impaired by exposure to chronic hypoxia, and there was evidence of suppression of
the sympathetic nervous system control of FHRV after 72 h of exposure to hypoxia (P < 0.001).
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This demonstrates that exposure to late gestation isolated chronic fetal hypoxia has the potential
to alter the development of the autonomic nervous system control of FHRV in sheep. This pre-
sents a potential mechanism by which a reduction in indices of FHRV in human fetuses affected
by uteroplacental dysfunction can predict fetuses at increased risk.
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Introduction
Antenatal electronic monitoring of fetal heart rate
variability (FHRV) is an important clinical tool to assess
the fetal condition, as authoritatively described over many
years by Parer (Fox et al. 2000). It is routinely used to assess
fetal wellbeing in pregnancies affected by uteroplacental
dysfunctionandprofound, prolonged reductions inFHRV
are thought to represent acute fetal compromise (Turan
et al. 2007; Serra et al. 2008). A persistent reduction in
short term variation (STV) below 3 ms in the antenatal
period, within 24 h of delivery, is predictive of an increased
risk ofmetabolic acidosis in the neonate at birth, and early
neonatal death (Serra et al. 2008). As such, STV, as part
of computerised cardiotocography (CTG) examination, is
recommended for antenatal surveillance of human fetuses
with suspected uteroplacental dysfunction and chronic
fetal hypoxia to detect acute fetal distress (Royal College
of Obstetricians and Gynaecologists, 2013). However, the
physiological basis underlying this reduction in FHRV
remains unclear.
The fetal heart rate (FHR)fluctuates under the influence
of basal sympathetic andparasympathetic tone, the central
nervous system, chronotropic hormones and different
fetal sleep states (Nijhuis et al. 1982), and it also has
some intrinsic variability (Kimura et al. 1996). The
sympathetic and parasympathetic influences on FHRV
mature at different rates throughout gestation (Walker
et al. 1979), and their relative contributions can be
assessed by indirect indices, time domain and power
spectral analysis. Assessment of these indices mandates
the insertion of a fetal electrode, arterial catheter or flow
probe, which has significantly limited human studies in
this field and thereby clinical application (Peters et al.
2004). Recently, fetal magnetic resonance imaging (MRI)
has been used to acquire FHR on a sufficiently accurate
beat-to-beat basis to allow such analysis, termed a fetal
magnetocardiogram (fMCG) (Ferrario et al. 2009; Sriram
et al. 2013).
Time domain and power spectral indices of FHRV
need to be separated by fetal behavioural state. Fetal
behavioural states (1F–4F) relate to quiet and active sleep
(1F = quiet sleep, 2F = active sleep, 3F = fetal breathing
or thumb sucking, 4F = gross fetal movements). The
correlation between oscillation bandwidth of heart rate
variability and frequency of accelerations of fetal heart rate
is sufficiently strong that different states canbedetermined
by visual identification of heart rate patterns alone
(Schaffer et al. 2009), an established method previously
used in this field (van Laar et al. 2009). Ultrasound-CTG
studies (Henson et al. 1984), fMCG studies (Sriram et al.
2013), as well a fetal electrocortical studies in chronically
instrumented sheep (Keen et al. 2011) demonstrate
that the relative time spent in each behavioural state
is unchanged between healthy and chronically hypoxic
fetuses.
A recent elegant study investigated thenormal evolution
of frequency power spectra over the last third of gestation
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in chronically instrumented, healthy singleton fetal sheep
at 0.6, 0.7 and 0.8 of gestation. The study reported that
total spectral power increased with advancing gestational
age, and that sympathetic dominance of FHRV was more
evident in active than quiet sleep (Koome et al. 2014a).
Similar studies in chronically hypoxic sheep fetuses have
not been reported to date. Progress in this field has been
hampered in part by the inability to record continuous
cardiovascular function in the fetus during the period
of chronic fetal hypoxia. We have now designed and
created isobaric hypoxic chambers able to maintain pre-
gnant sheep for prolonged periods of gestation under
controlled, long-term hypoxia (Brain et al. 2015).We have
also established a wireless data acquisition system, able
to record fetal cardiovascular signals from free-moving
ewes as the hypoxic pregnancy is developing (Brain et al.
2015; Allison et al. 2016). In this study, we have used
these novel technologies to determine a longitudinal study
of the development of FHRV, assessed by time domain
and power spectral analysis, in normoxic and chronically
hypoxic, chronically instrumented, singleton fetal sheep
over the last third of gestation. The last third of gestation
was chosen as the period of chronic hypoxia as this is
the time of maximal fetal growth, a period known to be
affected by chronic fetal hypoxia.
The study tested the hypothesis that hypoxia induced in
the last third of gestation in sheep affects the autonomic
regulation of the ontogeny of the fetal heart rate power
spectrum, thereby contributing to a reduction in FHRV.
Methods
Ethical approval
All procedures were performed in accordance with the
UK Animals (Scientific Procedures) Act 1986 and were
approved by the Ethical Review Board of the University of
Cambridge.
Surgical preparation and post-operative care
Twelve pregnantWelshmountain sheep carrying singleton
fetuses were used in the study. In brief, using the protocol
described in Allison et al. (2016), at 117 ± 1 days of
gestation (0.8 of gestation; term 150 days), general
anaesthesia was induced using 1.5–2.5 mg kg−1 I.V.
alfaxalone (Jurox Ltd, Malvern, UK). The ewe was
intubated with a cuffed endotracheal tube and anaesthesia
was maintained by inhalation of 1.5% isoflurane in
oxygen. Under aseptic surgical conditions, an arterial
catheter was inserted into the fetal femoral artery and
advanced into the descending aorta. Another catheter was
placed in the amniotic cavity. Following surgery, eweswere
housed in individual floor penswith a 12h light–dark cycle
with ad libitum access to hay, nuts and water. After 5 days
post-operative recovery, ewes and fetuses were randomly
allocated to chronic normoxia (n = 6) or chronic hypo-
xia (n = 6). Chronically hypoxic animals were housed
in bespoke isobaric hypoxic chambers (Fig. 1) for 2 days
prior to the initiation of hypoxia, and remained in these
chambers for a further 10 days under hypoxic conditions,
before being returned to the individual floor pens and
normoxic conditions. Hypoxia was induced incrementally
over the first 24 h, thenmaintained at 10% inspired oxygen
for the remainder of the experimental protocol, the full
details of which have been previously described (Brain
et al. 2015; Allison et al. 2016). Pregnancies allocated to
the chronic normoxia group were housed in a barn in
floor pens with the same floor area as that of the hypoxic
chambers. Both the chronic normoxia and hypoxia groups
of ewes were fed daily the same bespoke maintenance diet
made up of concentrate pellets and hay (40 g nuts kg–1
and 3 g hay kg–1; Manor Farm Feeds Ltd, Oakham, UK)
to facilitate the monitoring of food intake. Ambient room
temperature wasmaintained between 20 and 24°C in both
the hypoxic chambers and the normoxic floor pens. At the
end of the experimental protocol the ewe and fetus were
killed under Schedule 1 of the UK Animals (Scientific
Procedures) Act 1986 using a slow I.V. injection into the
maternal jugular vein of 120 mg kg−1 pentobarbitone
sodium (Pentoject; Animalcare Ltd, York, UK).
Fetal heart rate recording and identification of sleep
state
The fetal arterial and amniotic catheters were connected to
pressure transducers (ArgoTrans; Argon Medical Devices
Inc., Frisco, TX, USA). This allowed measurement of
continuous changes in fetal pulsatile arterial blood
pressure. From this, the inter-beat interval (equal to the
time between systolic peaks) could be assessed and time
domain and power spectral analyses calculated.
Continuous physiological values of fetal heart rate were
recorded using a customised data acquisition system,
CamDAS (Fig. 1), from the immediately post-operative
period to the end of the experiment (Allison et al. 2016).
These data were converted into absolute physiological
values by IDEEQdata recording software at a sampling rate
of 500 kHz (IDEEQ, Maastricht Instruments, Maastricht,
The Netherlands), and was available thereafter for offline
data analysis. Fetal heart rate was sampled daily in
5 min blocks spaced every 30 min between midnight
and 06.00 h. This time frame was selected as the period
when ewes were least likely to be disturbed by human
activity in the research facility. Therefore, a total of
30 min of FHR per 24 h was available for further analysis.
Five-minute epochs were chosen for analysis as this is
the established recommended length of time over which
standard deviation of normal to normal R-R intervals
(SDNN) should be calculated, and does not affect the
calculation of low frequency (LF), high frequency (HF),
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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total power or STV (Malik et al. 1996). Mean values for
sequential 2.5 s epochs throughout the recording period
were generated for cardiovascular data using Labchart 7
Pro (ADInstruments Pty Ltd, Bella Vista, NSW, Australia)
and used to create a CTG of fetal heart rate (Fig. 2). This
allowed visual interpretation of the fetal heart rate pattern.
Segments were then visually identified as FHR patterns
A–D (correlating to fetal behaviour states 1F–4F); quiet
sleep was defined as FHR pattern A and active sleep as
FHR pattern B. Records classified as FHR pattern A or B
were included; FHR patterns C and D were excluded. If
no suitable FHR pattern was acquired, re-sampling was
performed within the same time period for that day.
Fetal heart rate variability analysis
Time domain and power spectral analysis was performed
in Labchart 7 Pro (ADInstruments). The time between
successive systolic peaks in arterial blood pressure were
used to define the R–R inter-beat interval. Based on
previously published literature the frequency boundaries
used were: very low frequency (VLF) 0–0.04 Hz,
LF 0.04–0.15 Hz and HF 0.15–0.4 Hz (Min et al. 2002;
van Laar et al. 2009; Koome et al. 2014b). Mean daily
values for average heart rate, SDNN, root mean square
of the successive differences (RMSSD), absolute and
normalised LF and HF, LF/HF ratio, absolute VLF and
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Figure 1. Isobaric hypoxic chambers and the CamDAS system
Each chamber was equipped with an electronic servo-controlled humidity cool steam injection system to return the
appropriate humidity to the inspirate (i). Ambient PO2 , PCO2 , humidity and temperature within each chamber were
monitored via sensors (ii). For experimental procedures, each chamber had a double transfer port (iii) to internalise
material and a manually operated sliding panel (iv) to bring the ewe into a position where daily sampling of blood
could be achieved through glove compartments (v). Each chamber incorporated a drinking bowl on continuous
water supply and a rotating food compartment (vi) for determining food intake. A sealed transfer isolation cart
could be attached to a side exit (vii) to couple chambers together for cleaning. The CamDAS systemwas contained in
a custom-made sheep jacket able to hold the data acquisition system box (ix) in one side pouch and a box containing
the pressure connectors (x) in the other. Cables (xi) connected the two boxes together and also to two battery packs
able to power the system for 24 h. Measurements made using the data acquisition were transmitted wirelessly
via Bluetooth (xiii) to a laptop kept outside the chamber room (xii) on which it was possible to view continuous
recordings of the maternal and fetal cardiovascular data (reproduced with permission, Allison et al. 2016).
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total power were calculated daily from the categorised
5 min samples. The baseline value quoted represents
an average of 72 h (days 3–5 post-surgery). STV was
calculated using R–R intervals: first, average heart rate
was used to calculate the baseline R–R value; second, the
baselineR–R valuewas used to exclude values representing
accelerations (10 beats min−1 above baseline for15 s)
or decelerations (20 beats min−1 below baseline for
30 s) as these are excluded by STV calculation software
(Pardey et al. 2002). The remaining values were averaged
in 3.75 s (1/16th min) epochs and the mean difference
between16 sequential periods (1minmeandifference)was
calculated as per published STV calculation algorithms
(Street et al. 1991). Final STV values are the mean of
the 5 min mean difference values. All these values were
compared between normoxic and hypoxic pregnancies in
quiet and active sleep states.
Blood sampling regime and analysis
Samples of descending aortic fetal (0.3 ml) and maternal
(1 ml) blood were taken daily. These were used to
determineacid–base status, andpartial pressuresofoxygen
and carbon dioxide (ABL5 Blood Gas Analyser, Radio-
meter, Copenhagen, Denmark), and haemoglobin and
oxygen saturation of the blood (OSM3, Radiometer).
Determination of hormone concentrations
An additional 1 ml of fetal arterial blood was taken
after 5 days post-operative recovery (baseline) and
2 days after removal from chronic hypoxia, or equivalent
time in normoxic controls (day 13) for determination
of plasma cortisol and catecholamine concentrations.
Blood was collected into EDTA, centrifuged for plasma
extraction and frozen at−80°C. The concentration of fetal
cortisol in plasma was quantified using a commercially
available cortisol indirect enzyme-linked immunosorbent
assay (ELISA) kit according to the product instructions
(RE52061, IBL International, Hamburg, Germany). This
assay has previously been validated for use in fetal ovine
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Figure 2. Fetal heart rate variability patterns
A representative example of active sleep (left) and quiet sleep (right)
categorised by visual identification.
plasma (Kabaroff et al. 2006). Duplicate 20 μl plasma
aliquots (undiluted)were taken frompreviously unthawed
samples. The inter-assay and intra-assay coefficients of
variationwere5.2%and5.0%, respectively.The lower limit
of detection was 3.2 ng ml−1. The concentrations of fetal
noradrenaline and adrenaline in plasma were quantified
using a commercially available ELISA kit according to
product instructions (KA1877, Abnova, Taipei, Taiwan)
which has been previously optimised and validated for
ovine plasma in our laboratory (Brain et al. 2015).
Duplicate 300 μl volumes of previously unthawed plasma
were used to extract noradrenaline and adrenaline. For
noradrenaline, the inter-assay and intra-assay coefficients
of variation were 12.8% and 14.6%, respectively, and the
lower limit of detection was 0.05 ng ml−1. For adrenaline,
the inter-assay and intra-assay coefficients of variation
were 9.7% and 15.7%, respectively, and the lower limit
of detection was 0.01 ng ml−1.
Statistical analyses
Values are expressed as mean ± SEM. Statistical analysis
was performed in SPSS 22.0 (SPSS Inc., Chicago, IL,
USA). Repeated measures (RM) two-way ANOVAs were
performed: if a significant interaction between gestational
age and oxygenation was identified, post hoc Holm–Sidak
testswereperformed to assess the effect of oxygenation and
post hoc Tukey’s tests were performed to assess the change
from baseline with advancing gestational age. Normality
was assessed with the Shapiro–Wilk test and for normally
distributed data means were compared with Student’s
t test. Statistical significance was accepted when P < 0.05.
Results
Maternal and fetal oxygenation, acid–base and
endocrine status
Baseline values for maternal and fetal pH, partial pressure
of arterial oxygen (PaO2) and carbon dioxide (PaCO2)
and the saturation of oxyhaemoglobin (Sat.Hb) were
not different between groups prior to randomisation to
chronic hypoxia or normoxia (Fig. 3), and were within
normal ranges forWelshmountain ewes at this gestational
age (Fletcher et al. 2003, 2006). Daily maternal food
intake at baseline was not different between groups:
1.3 ± 0.9 kg day−1 (to be assigned normoxia) and
1.1 ± 0.4 kg day−1 (to be assigned hypoxia) and maternal
food intake was not affected by exposure to chronic hypo-
xia (Brain et al. 2015).
There was a significant fall in maternal and fetal PaO2
and Sat.Hb during the period in which the fraction of
maternal inspired oxygen was reduced to 10% in the
chronic hypoxia group; maternal and fetal oxygenation
levels remained stable in the normoxic control group.
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 3. Maternal and fetal blood gas, acid–base status during chronic normoxia and hypoxia
Values represent the mean ± SEM (n = 12) for arterial pH, partial pressure of arterial carbon dioxide (PaCO2 )
and oxygen (PaO2 ) and percentage oxygen saturation of haemoglobin (Sat.Hb). Chronic hypoxia, filled circles;
chronic normoxia, open circles. Significant differences (P < 0.05): ∗significant main effect of hypoxia compared
with normoxia; ‡significant main effect of time in hypoxic pregnancy on each individual day 1–13 when compared
to the baseline period (RM two-way ANOVA with post hoc Holm–Sidak and Tukey’s tests).
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There was no effect of time or oxygenation on maternal
or fetal pH, and maternal PaCO2 was unaffected by time or
treatment. However, fetal PaCO2 was reduced by the effect
of chronic hypoxia (Fig. 3).
Baseline (122 ± 1 days gestational age (GA)) fetal
cortisol, noradrenaline and adrenaline concentrations in
plasma were not different between animals to be assigned
to either chronic normoxic or chronic hypoxia treatment
groups. There was a gestational age-dependent rise in fetal
plasma cortisol concentration by the time of the second
sample (136 ± 1 days GA). However, the magnitude of
the ontogenic increase in fetal plasma cortisol was not
affected by whether the fetus had previously been exposed
to chronic hypoxia or normoxia. There was no change in
concentration of plasma catecholamines related to either
gestational age or treatment group (Table 1).
Effects on FHRV of gestational age and of chronic
hypoxia
A total of 882 FHR records were analysed in this study,
107 (12%) during quiet sleep (FHR pattern A) and 477
(54%)during active sleep (FHRpatternB). The remainder
of the FHR patterns (34%) were either C or D. This
distribution of fetal sleep states is expected from the
observed distribution of fetal behavioural states at these
gestational ages (van Woerden & van Geijn, 1992). In the
normoxic group, 381 of 505 FHR records were in either
pattern A or B (75%); in the hypoxic group 501 of 702
(71%) were in either pattern A or B (χ2 test, P = 0.11).
In the baseline state, prior to randomisation to chronic
normoxia or hypoxia, there were no differences between
the fetal absolute heart rate or any indices of fetal heart rate
variability based on their future treatment group. There
was no effect of sleep state on fetal heart rate between quiet
and active sleep. However, there was an effect of sleep state
at 0.8 of gestation observed in SDNN, STV, total power,
LF, HF, VLF, LF/HF ratio, but not RMSSD (Table 2).
In both quiet and active sleep states, therewas a decrease
in average fetal heart rate with increasing gestational age.
However, this fall was greater in the chronically hypo-
xic group than in normoxic pregnancies (Fig. 4). There
was a corresponding gestational age-dependent increase
in FHRV in the normoxic group. Measured by SDNN
and STV, this reached significance 9 days after baseline
in active sleep. In normoxic pregnancy in quiet sleep,
STV first showed a significant rise 7 days after base-
line, and was consistently elevated 10 days after base-
line. However, the trend to increase observed in SDNN
did not reach significance over the period assessed. This
increase in overall FHRV was not observed in the chronic
hypoxia group, in either quiet or active sleep, measured
by SDNN or STV. An oxygenation-dependent difference
between groups in STVandSDNNwasobserved, although
this occurred earlier in active sleep than quiet sleep
(Fig. 4). In normoxic pregnancies in active sleep there
was an increase of total power with gestational age which
related temporally to changes in STV and SDNN, reaching
significance at 9 days after baseline. Again, this increase
was not observed in chronically hypoxic pregnancies,
and there was an oxygen-dependent difference between
groups observed consistently from 9 days after baseline
measurements (Fig. 4). There were no sustained changes
of either gestational age or chronic hypoxia relating to total
power in quiet sleep.
In active sleep in normoxic pregnancy, there was a
progressive increase in LF with increasing gestational
age, which reached significance 11 days after baseline.
However, when these values were related to increases in
total power, there was no increase in normalised LF with
gestation. In chronic hypoxia, after the initial response
to the fall in oxygenation, there was a general trend
for a decrease in both LF and normalised LF in active
sleep. By 7 days after baseline, there was a significant
difference in both LF and normalised LF in active sleep
between normoxic and chronically hypoxic fetuses. This
depression of LF andnormalised LF in chronically hypoxic
fetuses persisted to the end of the period of assessement
(Fig. 5). There were no sustained differences seen in LF
or normalised LF with gestational age or oxygenation
seen in quiet sleep. Conversely, in quiet sleep there was
a gestational age-dependent increase in both HF and
normalisedHF observed from 9 and 10 days after baseline,
respectively, in both normoxic and chronically hypoxic
pregnancies, with no effect of treatment. This increase was
not mirrored in RMSSD. There were no changes observed
in parasympathetic indices of control of FHRV in active
sleep (Fig. 6).
In active sleep in normoxic pregnancy there was a
gestational age-related increase in the LF/HF ratio, which
reached significance 11 days after baseline. Conversely,
in hypoxic pregnancy there was a gestational age-related
fall in the LF/HF ratio, which reached significance
at 10 days after baseline. Accordingly, there was an
oxygenation-dependent significant difference between
groups evident 12 days after baseline. In quiet sleep, there
was a significant shift to sympathetic dominance at the
time of onset of hypoxia compared to normoxic pre-
gnancies which shifts towards sympathetic suppression
as the chronic hypoxia persists and an oxygenation effect
measured from days 5 to 8 after baseline (Fig. 7).
Discussion
This longitudinal study demonstrates that induction of
late gestation chronic hypoxia has the potential to alter
the development of autonomic nervous system control
of FHRV in sheep, supporting the hypothesis tested.
Exposure of pregnant ewes to a reduced fraction of
inspired oxygen produced a sustained reduction in fetal
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 4. Ontogenic changes in fetal heart rate and variability during chronic normoxia and hypoxia
Values represent the mean ± SEM (n = 12) for absolute fetal heart rate, SDNN, short term variation (STV) and
total power in quiet and active sleep. Period of chronic hypoxia (filled circles) or normoxia (open circles) indicated
by dashed box. ‘B’ represents an average of values taken in the 72 h period −2 to 0. Significant differences
(P < 0.05): ∗significant effect of oxygenation between treatment groups; †significant effect of gestational age in
normoxic pregnancy on each individual day 1–13 when compared to the baseline ‘B’ period; ‡significant effect of
gestational age in hypoxic pregnancy on each individual day 1–13 when compared to the baseline ‘B’ period (RM
two-way ANOVA with post hoc Tukey’s and Holm–Sidak tests).
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Table 1. Ontogenic changes in fetal cortisol and catecholamines during chronic hypoxia and normoxia
Normoxia Hypoxia
Baseline Day 13 Baseline Day 13
Cortisol (ng ml−1) 11.9 ± 1.4 24.1 ± 1.8∗ 13.8 ± 1.8 32.2 ± 5.2∗
Noradrenaline (ng ml−1) 1.1 ± 0.3 0.8 ± 0.1 0.7 ± 0.1 0.6 ± 0.1
Adrenaline (ng ml−1) 0.09 ± 0.02 0.07 ± 0.02 0.06 ± 0.01 0.07 ± 0.01
Values represent the mean ± SEM of plasma concentrations of fetal cortisol, noradrenaline and adrenaline at baseline (122 ± 1 days
GA) and 2 days after the end of chronic hypoxia/normoxia (day 13, 136 ± 1 days GA). Significant differences (P < 0.05): ∗significant
effect of gestational age (RM two-way ANOVA with post hoc Tukey’s test).
Table 2. Effect of sleep state on FHRV indices before onset of chronic normoxia or hypoxia
Active sleep 0.8
gestational age
Quiet sleep 0.8
gestational age P value
Fetal heart rate (beats min−1) 173 ± 1.5 175.6 ± 1.6 0.2625
Standard deviation of normal to normal R-R intervals (SDNN) (ms) 12.5 ± 0.4 6.7 ± 0.3∗ <0.001
Short term variation (STV) (ms) 4.7 ± 0.2 2.6 ± 0.1∗ <0.001
Total power (ms2) 166 ± 11.1 6.2 ± 0.7∗ <0.001
Low frequence (LF) power (ms2) 82.6 ± 7.4 8.2 ± 1.4∗ <0.001
High frequency (HF) power (ms2) 19 ± 1.7 5.9 ± 0.6∗ <0.001
LF/HF ratio 4.7 ± 0.5 1.5 ± 0.2∗ <0.001
Root mean square of the successive differences (RMSSD) (ms) 8.3 ± 0.6 7.6 ± 0.8 0.5148
Values represent the mean ± standard error of the mean (n = 12) for fetal heart rate and indices of fetal heart rate variability in quiet
and active sleep. Significant differences (P < 0.05): ∗significant effect of sleep state (Student’s t test).
femoral arterial PO2 to 10–12 mmHg between 0.8 and 0.9
of gestation. This represents an estimated 50% reduction
in the normal oxygenation values of the fetal umbilical
artery, 20mmHg (Longo, 2013). Reductions of a similar or
greater magnitude have been measured through sampling
the umbilical vein in growth-restricted human fetuses
at comparable points in gestation (Soothill et al. 1987;
Nicolaides et al. 1989). There was also a reduction in fetal
arterial PCO2 in response to chronic hypoxia. This may
suggest an alteration in the rate of fetal metabolism due
to hypoxia, with a reduction in fetal oxygen consumption
leading to a decrease in the production of fetal CO2 (see
Allison et al. 2016). Therefore, the degree of chronic fetal
hypoxia achieved in this study and the impact on fetal
metabolism suggest this model is relevant to the human
clinical situation in pregnancy complicated by significant
fetal growth restriction.
In our study in normoxic fetuses there was an ontogenic
increase inFHRV indices of overall variability (total power,
SDNN) as well as an increase in STV with advancing
gestation. The basal fetal heart rate also fell. These changes
weremorepronounced in active sleepbutwere still evident
in quiet sleep. Total power has previously been shown
to increase with advancing gestational age in fetal sheep
(Koome et al. 2014a) and STV, measured by computerised
CTG, has been observed to increase towards term in
the human fetus (Serra et al. 2009). The mean STV
values for our normoxic sheep fetuses fall between the
10th–50th centile of the published ranges for human
fetuses at an equivalent gestational age, despite not being
measured by computerised CTG in our fetuses (Serra
et al. 2009). Therefore, our control group shows the
expectedontogenic changes over theperiod studied,which
represents approximately 10% of the total gestational
period in sheep.
In the present study, exposure to chronic hypoxia pre-
vented the ontogenic increase in FHRV indices of overall
variability and STV, in both active and quiet sleep states,
and accentuated the fall in basal fetal heart rate. Compared
to their normoxic counterparts at an equivalent gestational
age, STV, SDNN and total power were lower in chronically
hypoxic fetuses, even after their return to normoxia.
Despite this, the STV remained above 3 ms in hypoxic
fetuses in active sleep states, which correlated well with
the normal fetal arterial pH values observed throughout,
and fetal survival to the end of the experimental procedure
in all cases. Changes in cardiovascular function in these
fetuses have been published previously (Allison et al.
2016). Chronic hypoxia diminished the ontogenic rise in
fetal mean arterial blood pressure (fMAP) over the same
period as this study, although the absolute difference by
day 13 was <5 mmHg. There is a positive correlation
between increases in mean arterial pressure and overall
FHRV in the last third of gestation in fetal sheep, which
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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is abolished by vagal blockade (Yu & Lumbers, 2000).
However, in these studies, an increase in 10 mmHg of
fMAP resulted in a <1% increase in overall FHRV (Yu &
Lumbers, 2002). This is therefore unlikely to underlie the
changes in FHRV or basal FHR seen.
Fetal breathing movements were not assessed in this
study. In human fetuses, based on fMCG studies, fetal
breathing episodes have been shown to increase both over-
all variability and HF power, and decrease basal heart
rate (Gustafson et al. 2011). Furthermore, seminal studies
have reported that chronic fetal hypoxia leads to a fall
rather than an increase in the incidence of fetal breathing
movements (Richardson et al. 1992). In fetal sheep, the
effect of fetal breathing has been shown to account for less
than 10%variation of the fetal heart rate, and changes pre-
dominantly result in a shift of power toHF, not an increase
in total power, unlike the situation in the adult (Metsala
et al. 1993). This is attributed to the small volume changes
observed in the fetal lungs during in utero breathing
compared to the adult tidal volume (McLain, 1964). Fetal
breathing also produces a characteristic fetal heart rate
pattern of respiratory sinus arrhythmia (pattern C) which
correlates with fetal sleep state 3F, which should have been
excluded from this study.
In human fetuses, impaired increases in overall heart
rate variability with increasing gestational age, measured
by computerised CTG, have been described in fetuses
affected by uteroplacental dysfunction (Lobmaier et al.
2012). Similarly, fMCG studies have demonstrated a
lower SDNN in human fetuses affected by uteroplacental
dysfunction thanwas calculated in gestation age-matched,
normally grown controls (Sriram et al. 2013). Therefore,
the data in our study highlight that changes in FHRV
measured in human pregnancy affected by uteroplacental
dysfunction are likely due to isolated chronic fetal hypoxia.
Both SDNN and STV are decreased in sympath-
ectomised sheep compared to controls (Lear et al. 2016),
as is total power (Koome et al. 2014a). Although resting
sympathetic tone is low in the fetus (Assali et al. 1977),
the sympathectomy studies suggest a significant role for
the sympathetic nervous system in contributing to the
ontogenic changes in FHRV. Sympathetic innervation is
completed by the second half of pregnancy and increases
gradually towards term in fetal sheep (Lebowitz et al.
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1972). Conversely, the parasympathetic system, while
active in the last third of gestation and exhibiting control
over the FHR, does not begin to increase resting tone
until term (van Laar et al. 2009). Consistent with the
literature, in our normoxic fetuses, in active sleep, LF
power, but not HF, normalised LF nor HF power, showed
an increase with gestational age. The LF/HF ratio also
increased with gestational age, suggesting an ontogenic
shift towards sympathetic dominance as the healthy fetus
approached term. Compared to normoxic fetuses, the
LF and normalised LF power was significantly lower
in chronically hypoxic fetuses in active sleep, while HF
and normalised HF power remained unchanged. This
resulted in an ontogenic decrease rather than increase
in LF/HF ratio, and a marked difference in LF/HF ratio
between normoxic and chronically hypoxic fetuses by
the end of the experimental protocol. This appeared to
be due to a reduction in the influence of the sympathetic
nervous system on the control of FHRV, rather than due
to changes in the parasympathetic nervous system in
the chronically hypoxic fetus. As previously described,
the impaired ontogenic increase in mean arterial pressure
in the chronically hypoxic fetuses (Allison et al. 2016)
would not be expected to affect the increase of power in
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the LF spectrum, or promote a shift toward sympathetic
domination (Yu & Lumbers, 2002). In theory, due to
the impaired rise in mean arterial blood pressure, an
increase in HF power could have been expected, but
this was not seen. This is likely due to the small, but
significant, absolute difference in fetal mean arterial blood
pressure between the normoxic and chronically hypoxic
fetuses. This reduction in the influence of the sympathetic
nervous system could also underlie the change in basal
heart rate in the chronically hypoxic fetus.
The chronically hypoxic fetuses were, at the start
of the experimental protocol, capable of increasing the
sympathetic control of FHRV in response to an acute
challenge. There was an increase in LF, normalised LF
and the LF/HF, seen in quiet sleep, during the first 48 h
of exposure to hypoxia, representing a prolonged period
of sympathetic dominance in the control of FHRV. This
increase in sympathetic nervous output is a characteristic
response to acute hypoxia, and forms part of the fetal
cardiovascular defence mechanism to hypoxic episodes
(Giussani, 2016). However, the increased sympathetic
tone cannot be maintained indefinitely, and blunting
of fetal heart rate and peripheral vascular responses
to sympathetic activity has been reported after around
72 h (Bennet & Gunn, 2009). In our animals, it is
only after this time that the reduction in sympathetic
contribution of FHRVbecomes evident. This likely under-
lies the delay in onset of the fall in basal FHR seen
in chronically hypoxic fetuses. Therefore, unlike the
normoxic fetuses, in which the trend was to develop
sympathetic dominant control of FHRV approaching
term, the trend in the chronically hypoxic fetus was
towards overall sympathetic suppression, despite a normal
ontogenic rise in fetal plasma cortisol levels. The fetal end-
ocrine data are in keeping with studies of ovine pregnancy
at high altitude. Such studies have reported that ovine
fetuses exposed to chronic hypoxia have unaltered levels of
basal cortisol and catecholamines compared to normoxic
controls at corresponding gestational ages (Newby et al.
2015). This study, however, was not able to suggest
the mechanism by which this sympathetic suppression
occurred in chronically hypoxic fetuses, given that no
changes in fetal basal cortisol or catecholamine levels were
detected, andnoother assessment of sympathetic function
or innervation was performed.
The findings reported in the present study agree with
fMCG studies, which show a progressive increase in LF
power in normoxic human pregnancy (Ferrario et al.
2009; Schneider et al. 2010). The LF/HF ratio in human
pregnancies also shows an ontogenic increase and a
change towards sympathetic dominance during the third
trimester (Schneider, 2009; Fukushima et al. 2011), while
HF power remains unchanged (Ferrario et al. 2009).
Lower values of LF/HF ratio are associated with decreased
overall FHRV (Ferrario et al. 2009) and STV (Schneider
et al. 2010). In human fetuses in pregnancy complicated
by uteroplacental dysfunction, overall FHRV is reduced
due to a reduction in the sympathetic contribution to
the control of the fetal heart, while the parasympathetic
contribution remains unchanged (Ferrario et al. 2009;
Sriram et al. 2013). A decrease in LF has been linked
to an umbilical artery PO2 < 20 mmHg at delivery
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(Ohta et al. 1999; Suzuki et al. 2000). Our studies again
highlight that sympathetic suppression in the control of
FHRV in the late gestation human fetus in complicated
pregnancy is likely due to isolated chronic hypoxia.
Collectively, past and present data suggest that a reduction
in overall FHRV in the human fetus, as in fetal sheep,
may be due to sympathetic suppression rather than an
increase in parasympathetic tone. Appropriate activation
of the sympathetic nervous system in the late gestation
fetus is an indispensable component of the fetal homeo-
static compensatory response to acute stress, such as in
response to acute reductions in fetal oxygenation or acute
hypoxia (Giussani et al. 1993; Giussani, 2016). Therefore,
dysregulation of sympathetic control of the cardiovascular
system would predict that the chronically hypoxic fetus
may be more vulnerable to acute insults in late gestation.
Reduction in overall FHRV, or STV,may therefore provide
a biomarker that autonomic dysregulation of FHR control
has taken place in a fetuswhere uteroplacental dysfunction
is suspected. This study does not, however, suggest the
mechanism by which this dysregulation of sympathetic
control occurs in the chronically hypoxic fetus.
In conclusion, we present the first longitudinal study of
autonomic control of fetal heart rate variability in isolated
chronic fetal hypoxia.Wehavedemonstrated that FHRV in
sheep is reduced in chronic hypoxia, predominantly due
to dysregulation of the sympathetic control of the fetal
heart rate. This presents a potential mechanism by which
a reduction in indices of FHRV in human fetuses predicts
an increased risk of birth asphyxia.
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